Abstract:Objective. Radiotherapy (RT) is one of the main treatments for patients with unresectable hepatocellular carcinoma (HCC). Emerging evidence indicates that the cGAS-STING pathway is crucial in RT-induced antitumor immune response. Here, we discovered that activation of the cancer cell-intrinsic cGAS-STING pathway mediated immune cloaking resulting from RT-induced DNA damage. This provided a rationale for combining RT with programmed cell death 1 (PD-1) and its ligand (PD-L1) checkpoint blocking in treating HCC. Design. We analyzed changes in PD-L1 expression using 20 fixed HCC tissues from patients treated with preoperative RT and serum soluble PD-L1 (sPD-L1) expression after RT in another cohort of 118 HCC patients, and obtained survival data. We knocked out or knocked down key proteins in the cGAS-STING pathway in Huh7, HCCLM3, MHCC97H Huh7, H22, and Hepa1-6 HCC cell lines. H22 cells were transplanted into wild-type, cGAS-deficient (Mb21d1−/−), and STING-deficient (Tmem173gt) C57BL/6 mice. We performed RNA sequence, immunoblot, dual-luciferase reporter, and chromatin precipitation analyses of mouse liver and cell lines. Hep1-6 cells were used to generate orthotopic intrahepatic tumor models. Mice were administered combinations of RT and antibodies against PD-L1 (or PD-1) or antibodies to deplete T cells. Tumors were collected and analyzed by immunohistochemistry and flow cytometry. Results. RT upregulated PD-L1 in HCC patients, which correlated with poor survival. RT activated cGAS-STING and increased immune checkpoint PD-L1 expression in human and mouse liver cancer cells. Ionizing radiation activated the STING/TBK1/IRF3 innate immune pathway, leading to PD-L1 upregulation in HCC cells, which inhibits cytotoxic T lymphocyte activity and protects tumor cells from immune-mediated eradication. Knockdown of cGAS,STING, TBK1, and IRF3 reversed the antitumor effect of cytotoxic T lymphocyte-mediated cytotoxicity after ionizing radiation in vitro or in vivo. RT potentiated the antitumor effect of PD-1/PD-L1 axis blockade and augmented cytotoxic T-cell infiltration in HCC tumors in immunocompetent mice. Similar synergetic effects were observed in HCC tumors in Mb21d1−/− and Tmem173gt C57BL/6 mice, suggesting that the effects are independent of the host cGAS-STING pathway. CD8 depletion compromised the synergetic antitumor effect of combined RT and anti-PD-L1 blockade, demonstrating that CTLs are required for antitumor immunity induced by the combination therapy. Conclusion Our results identified an immune-cloaking mechanism of RT-activated innate immune cGAS-STING and show that RT could empower HCC immunotherapy. Citation Format: Shisuo Du, Genwen Chen, Ping Yang, Yixin Chen, Yong Hu, Zhaochong Zeng. Irradiation promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 6510.

HO-1 impairs the efficacy of radiotherapy by redistributing cGAS and STING in tumors

Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation

STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer

Single High-Dose Irradiation-Induced Irhom2 Upregulation Promotes Macrophage Antitumor Activity Through Cgas/sting Signaling

Irradiation promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation

Blockade of USP14 Potentiates Type I Interferon Signaling and Radiation-Induced Antitumor Immunity Via Preventing IRF3 Deubiquitination.

Abstract 6510: Irradiation Promotes Hepatocellular Carcinoma Immune Cloaking Via PD-L1 Upregulation Induced by Cgas-Sting Activation

Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response Via Inducing CD8+ T Cell Infiltration.

Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells

Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway

IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion

Radiation-Mediated Dna Sensing Pathway For Immunity And Tumor Regression

Abstract SY39-03: Radiation-mediated DNA Sensing Pathway for Immunity and Tumor Regression

DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury

Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling

Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy.

T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer

Activity of heme oxygenase-1 affects expression levels of hypoxia inducible factor-1 gene in vitro.

An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy

X‐ray Induced Release of Nitric Oxide from Hafnium‐Based Nanoradiosensitizers for Enhanced Radio‐Immunotherapy